AFP and neoplasm: There were no significant differences in general clinical data such as gender, age, Eastern Cooperative Oncology Group performance status (ECOG-PS), Child-Pugh class, BCLC stage, portal vein tumor thrombus, tumor number, tumor size, HBV, AFP, ALT and NLR among the three groups of patients before treatment (P>0.05).